Organization: Health Canada
Year: 2023
Month: May
Request Number: A-2022-001521
Request Summary: Adverse Drug Reactions (ADRs) for VYVANSE. Report numbers: 001022362, E2B_06007689, 001021585, 001022523. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_05981092, E2B_06009474, E2B_05986973, E2B_06029786. ADR for GAMMAGARD LIQUID. Report number: 001020081.
Disposition: Disclosed in part
Number of pages: 78